Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants will Support Early-Stage Science

NEW YORK (GenomeWeb News) – Under a grant program focused on early-stage ideas and technologies, the National Institutes of Health will give up to $275,000 over a two-year period to researchers seeking funding for potentially risky but rewarding studies.

The Exploratory/Developmental Grant Program will fund research through the National Human Genome Research Institute and other institutes that "may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research," NIH said in a request for applications.

These grants are specifically meant to encourage new research projects that are in the beginning or discovery phases of development.

Applicants for the funds may seek no more than $200,000 in funding per year.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.